The evolution and biology of SARS-CoV-2 variants
A Telenti, EB Hodcroft… - Cold Spring …, 2022 - perspectivesinmedicine.cshlp.org
Our understanding of the still unfolding severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic would have been extremely limited without the study of the …
(SARS-CoV-2) pandemic would have been extremely limited without the study of the …
Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
The rapid development of multiple vaccines providing strong protection from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major achievement …
Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum
A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc… - Cell, 2022 - cell.com
The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread
rapidly to become globally dominant and has split into a number of sublineages. BA. 1 …
rapidly to become globally dominant and has split into a number of sublineages. BA. 1 …
Evolution and neutralization escape of the SARS-CoV-2 BA. 2.86 subvariant
Abstract Omicron BA. 2.86 subvariant differs from Omicron BA. 2 as well as recently
circulating variants by over 30 mutations in the spike protein alone. Here we report on the …
circulating variants by over 30 mutations in the spike protein alone. Here we report on the …
Milder disease with Omicron: is it the virus or the pre-existing immunity?
A Sigal - Nature Reviews Immunology, 2022 - nature.com
Milder disease with Omicron: is it the virus or the pre-existing immunity? | Nature Reviews
Immunology Skip to main content Thank you for visiting nature.com. You are using a browser …
Immunology Skip to main content Thank you for visiting nature.com. You are using a browser …
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
Y Li, MC Choudhary, J Regan, J Boucau… - Science translational …, 2024 - science.org
Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …
SARS-CoV-2 omicron variant: epidemiological features, biological characteristics, and clinical significance
Y Guo, J Han, Y Zhang, J He, W Yu, X Zhang… - Frontiers in …, 2022 - frontiersin.org
The SARS-CoV-2 Omicron (B. 1.1529) variant was designated as a variant of concern (VOC)
by the World Health Organization (WHO) on November 26, 2021. Within two months, it had …
by the World Health Organization (WHO) on November 26, 2021. Within two months, it had …
SARS-CoV-2 evolution and immune escape in immunocompromised patients
EM Scherer, A Babiker, MW Adelman… - … England Journal of …, 2022 - Mass Medical Soc
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …
COVID-19: challenges of viral variants
The COVID-19 pandemic has been accompanied by SARS-CoV-2 evolution and
emergence of viral variants that have far exceeded initial expectations. Five major variants of …
emergence of viral variants that have far exceeded initial expectations. Five major variants of …
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
K van der Straten, D Guerra, MJ van Gils, I Bontjer… - Immunity, 2022 - cell.com
Large-scale vaccination campaigns have prevented countless hospitalizations and deaths
due to COVID-19. However, the emergence of SARS-CoV-2 variants that escape from …
due to COVID-19. However, the emergence of SARS-CoV-2 variants that escape from …